Global Cell Viability Assays Market – Industry Trends - Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • May 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Cell Viability Assays Market By Products (Consumables, Instruments), Cell Type (Human Cells, Microbial Cells, Animal Cells), Applications (Stem Cell Research, Clinical & Diagnostics Applications, Drug Discovery & Development, Basic Research, Other Applications), End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospital & Diagnostics Laboratories, Other End-Users), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Cell Viability Assays Market

Global Cell Viability Assays Market is expected to rise from its initial estimated value of USD 2.75 billion in 2018 to an estimated value of USD 5.30 billion by 2026, registering a CAGR of 8.57% in the forecast period of 2019-2026. The rise in the chronic diseases is the major factor for the growth of this market.

Market Definition: Global Cell Viability Assays Market

Viability means ability to survive or live. Cell viability is a homogeneous method to determine the number of cells that are dead or living on a total cell sample. They are usually based on the ongoing cellular metabolism and enzyme activity. The increase in the cell viability means that there is cell growth while decrease in the cell viability means that toxic effects of compound. To determine the optimal growth conditions of the cell populations often call viability is very useful.

Market Drivers

  • They can correlate the cell behavior to cell numbers.
  • Demand for the cell- based arrays is increasing the growth of this market.

Market Restraints

  • The costs of the instruments are very high, which can be the major factor to restraint the growth of this market.
  • Lack of the professionals and expert to run these instruments.

Segmentation: Global Cell Viability Assays Market

  • By Products

    • Consumables

      • Reagents
      • Assay Kits

        • Tetrazolium Reduction Assay Kits

          • MTT Assay Kits
          • Other Tetrazolium Assay Kits

        • Resazurin Cell Viability Assays Kits
        • Calcien- Am Cell Viability Assays Kits
        • Other Assay Kits

      • Microplates

    • Instruments

      • Automated Cell Counters
      • Flow Cytometers
      • Spectrophotometers
      • Cell Imaging and Analysis Systems

  • By Cell Type

    • Human Cells
    • Microbial Cells
    • Animal Cells

  • By Applications

    • Stem Cell Research
    • Clinical & Diagnostics Applications
    • Drugs Discovery and Development
    • Basic Research
    • Other Applications

  • By End-Users

    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Clinical & Diagnostics Applications
    • Hospital & Diagnostics Laboratories

  • By Geography

    • North America

      • US.
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia-Pacific

    • Middle East & Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • In January 2019, DeNovix announces the launch of their CellDrop Automated Cell Counter which does not require expensive, environmentally damaging plastics slides. The main aim is to eliminate the expensive automated cell counter.
  • In June 2018, Thermo Fisher Scientific Inc, and Roper Technologies Inc., announced the announced the agreement in which Thermo Fisher will acquire Gatan Inc., subsidiary of Roper for approximately $925 million. The main aim is to enhance the customers by creating an integrated system which connects microscope hardware, software and accessories.

Competitive Analysis:

Global cell viability assays market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cell viability assays market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the cell viability assays market are Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GENERAL ELECTRIC COMPANY, Danaher, BD, Promega Corporation, Biotium, Abcam plc, BioTek Instruments, Inc., PerkinElmer Inc., Pfizer Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc. and Gilead Sciences, Inc.

Research Methodology: Global Cell Viability Assays Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global cell viability assays market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE